WBA Stock Overview
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 3/6 |
Past Performance | 1/6 |
Financial Health | 3/6 |
Dividends | 2/6 |
Walgreens Boots Alliance, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$20.69 |
52 Week High | US$36.58 |
52 Week Low | US$19.68 |
Beta | 0.72 |
1 Month Change | -5.87% |
3 Month Change | -20.51% |
1 Year Change | -37.66% |
3 Year Change | -61.04% |
5 Year Change | -66.46% |
Change since IPO | 6,359.31% |
Recent News & Updates
Recent updates
Walgreens Q2, Dow Exit, And Bet Against Wall Street
Mar 15Walgreens: New CEO Looking To Right The Ship
Feb 13Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky
Jan 19Walgreens Boots Alliance: Income Opportunity After Dividend Cut
Jan 17Walgreens Q1: Dividend Cut Now What? (Rating Upgrade)
Jan 10After Leaping 26% Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Are Not Flying Under The Radar
Dec 24Walgreens Boots Alliance's (NASDAQ:WBA) Dividend Will Be $0.48
Oct 31Walgreens Boots Alliance (NASDAQ:WBA) Has A Somewhat Strained Balance Sheet
Oct 02Walgreens Boots Alliance (NASDAQ:WBA) Will Pay A Dividend Of $0.48
Aug 01Walgreens Boots Alliance (NASDAQ:WBA) Has Announced A Dividend Of $0.48
Jul 16Walgreens Boots Alliance (NASDAQ:WBA) Has A Somewhat Strained Balance Sheet
Jul 04Walgreens Boots Alliance's (NASDAQ:WBA) Dividend Will Be $0.48
Apr 25Walgreens Boots Alliance (NASDAQ:WBA) Has A Somewhat Strained Balance Sheet
Mar 08Walgreens Boots Alliance (NASDAQ:WBA) Has Affirmed Its Dividend Of $0.48
Feb 01Walgreens Boots Alliance's (NASDAQ:WBA) Dividend Will Be $0.48
Nov 01Walgreens Boots Alliance Dividend is Solid, but it Might Not be Enough
Oct 16Walgreens Boots Alliance - A Company In Transition
Oct 146%-Yielding Walgreens Is Now Ridiculously Cheap
Oct 08Here's Why Walgreens Boots Alliance (NASDAQ:WBA) Has A Meaningful Debt Burden
Oct 07Walgreens to buy remaining 30% stake in Shields Health for $1.37B
Sep 20Walgreens May Be A Falling Knife, Yet Suits Income Investors
Sep 04Shareholder Returns
WBA | US Consumer Retailing | US Market | |
---|---|---|---|
7D | -3.9% | 0.5% | 0.5% |
1Y | -37.7% | 23.9% | 29.0% |
Return vs Industry: WBA underperformed the US Consumer Retailing industry which returned 23.9% over the past year.
Return vs Market: WBA underperformed the US Market which returned 29% over the past year.
Price Volatility
WBA volatility | |
---|---|
WBA Average Weekly Movement | 5.1% |
Consumer Retailing Industry Average Movement | 4.6% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: WBA's share price has been volatile over the past 3 months.
Volatility Over Time: WBA's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1909 | 268,500 | Tim Wentworth | https://www.walgreensbootsalliance.com |
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S.
Walgreens Boots Alliance, Inc. Fundamentals Summary
WBA fundamental statistics | |
---|---|
Market cap | US$17.84b |
Earnings (TTM) | US$574.00m |
Revenue (TTM) | US$142.41b |
31.1x
P/E Ratio0.1x
P/S RatioIs WBA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
WBA income statement (TTM) | |
---|---|
Revenue | US$142.41b |
Cost of Revenue | US$115.52b |
Gross Profit | US$26.89b |
Other Expenses | US$26.32b |
Earnings | US$574.00m |
Last Reported Earnings
Nov 30, 2023
Next Earnings Date
Mar 28, 2024
Earnings per share (EPS) | 0.67 |
Gross Margin | 18.88% |
Net Profit Margin | 0.40% |
Debt/Equity Ratio | 33.3% |
How did WBA perform over the long term?
See historical performance and comparison